SEC Contract Filing

Filing Date: 2022-10-26

Document Content:
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>ex_437065.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html><head>
	<title>ex_437065.htm</title>
	<!-- Generated by ThunderDome Portal - 10/26/2022 6:28:10 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 10.2</b></font></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b><i>Execution Copy</i></b></p>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><img alt="aravive01.jpg" src="aravive01.jpg"></div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">October 24, 2022</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">c/o 667, L.P.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">860 Washington Street</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">New York, NY 10014</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">c/o Baker Brothers Life Sciences, L.P.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">860 Washington Street</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">New York, NY 10014</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-align: justify;"><b><i>Re:</i></b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><i>Participation, Board, Observer and Publicity Rights</i></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Ladies and Gentlemen:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Subject to and in consideration of the purchase of (i) shares of common stock, par value $0.0001 per share, (&#8220;<u>Common Stock</u>&#8221;), of Aravive, Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), (ii) pre-funded warrants to purchase Common Stock (&#8220;<u>Pre-funded Warrants</u>&#8221;), and (iii) warrants to purchase Common Stock or Pre-funded Warrants (the &#8220;<u>Common Warrants</u>&#8221; and, together with the Common Stock and the Pre-Funded Warrants, the &#8220;<u>Securities</u>&#8221;) by 667, L.P., Baker Brothers Life Sciences, L.P. and/or one or more of their respective Affiliates (as defined below) (each, an &#8220;<u>Investor</u>&#8221; and together, the &#8220;<u>Investors</u>&#8221;) pursuant to the terms and conditions of that certain Securities Purchase Agreement, by and among the Company, the Investors and the other parties named therein, dated as of the date hereof (the &#8220;<u>Purchase Agreement</u>&#8221;), the parties to this letter hereby agree as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">1.&nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp;&nbsp;<b><i>Participation Rights</i></b>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;"><i>a.</i><i>&nbsp; &nbsp; &nbsp; &nbsp; Non-Underwritten Offerings.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 99pt; text-align: justify;">i.&nbsp;&nbsp;&nbsp;&nbsp;If, during the period from the closing date of the purchases of Securities pursuant to the Purchase Agreement (the &#8220;<u>Closing Date</u>&#8221;) through and including the fifth (5<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup>) year anniversary of the Closing Date (the &#8220;<u>Participation Period</u>&#8221;), the Company proposes to offer and sell any New Securities (as defined below) in an offering that is conducted pursuant to an exemption from registration under the Securities Act of 1933, as amended (the &#8220;<u>Securities Act</u>&#8221;), or in an offering that is registered under the Securities Act that is not conducted as a firm-commitment underwritten offering, then, subject to compliance with all applicable securities laws and regulations, the Investors shall have the right to purchase, on the same terms, including the price per security, and subject to the same conditions, as are applicable to the other investors in such offering,